α1-Blockers for BPH (Tamsulosin, Doxazosin)
USMLE Step 1 trap: Confuses tamsulosin's uroselective α1A profile with non-selective α1 blockade causing significant hypotension. Tamsulosin is selective for α1A receptors (predominant in prostate/bladder neck) and causes less systemic hypotension than non-selective α1-blockers like doxazosin or terazosin.
α1-Blockers are a first-line treatment for BPH, and USMLE Step 1 tests them in two distinct ways: mechanism/selectivity and side effects. The core drugs are tamsulosin, doxazosin, terazosin, and alfuzosin — all block α1 receptors in the prostate smooth muscle and bladder neck to relieve urinary obstruction. The exam will give you a patient with obstructive urinary symptoms (hesitancy, weak stream, incomplete emptying) and ask you to identify the mechanism or choose between drug classes. The key distinction the exam exploits is tamsulosin's uroselective α1A profile versus the broader α1 blockade of doxazosin and terazosin.
The tricky part is keeping the mechanism clean. Students frequently blur α1-blockers with finasteride, thinking all BPH drugs shrink the prostate. They don't. α1-blockers are about muscle relaxation and work within days — finasteride is about hormonal prostate shrinkage and takes months. The exam will sometimes present a scenario requiring rapid symptom relief or contrast the two drug classes directly; you need to know which does what without hesitating.
The most commonly missed point on USMLE Step 1 is the floppy iris syndrome connection. Tamsulosin causes intraoperative floppy iris syndrome (IFIS) during cataract surgery because it blocks α1 receptors in the iris dilator muscle, causing the iris to billow and prolapse. A vignette will often frame this as a preoperative disclosure question or an intraoperative complication in an older man — and students who only know 'tamsulosin relaxes prostate smooth muscle' will miss it entirely.
A gap in most decks — fewer than half of students in our cohort have cards covering this topic.
Common misconceptions
What the exam tests
- Given a drug name (tamsulosin vs. doxazosin), identify the receptor subtype selectivity and predict whether significant systemic hypotension is expected as a side effect.
- Explain the mechanism by which α1-blockers relieve BPH symptoms — specifically, which tissue they act on and why symptoms improve quickly (within days).
- Recognize intraoperative floppy iris syndrome as a complication of tamsulosin in a patient undergoing cataract surgery, and understand why preoperative disclosure to the ophthalmologist is required.
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →